<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9077">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05705726</url>
  </required_header>
  <id_info>
    <org_study_id>524/2022</org_study_id>
    <nct_id>NCT05705726</nct_id>
  </id_info>
  <brief_title>Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur</brief_title>
  <official_title>Ultrasound Guided Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur Patients During Spinal Anesthesia: Randomized Comparison Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Proximal femur fractures are one of the commonest fractures especially in the elderly&#xD;
      population. Early surgical fixation is the best analgesic for associated pain. Spinal&#xD;
      anesthesia has been favored by many anesthesiologists due to the simplicity of the technique,&#xD;
      the better analgesic profile, and the lower incidence of complications like delirium and&#xD;
      thromboembolic events. However, severe pain, encountered during positioning for spinal&#xD;
      anesthesia, can complicate the technique and worsen the patient experience.&#xD;
&#xD;
      the study aim to compare the analgesic effect of intravenous dexmedetomidine and fascia&#xD;
      iliaca block preoperatively to assist positioning patients for performance of spinal&#xD;
      anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 11, 2023</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Behavioral pain scale</measure>
    <time_frame>during spinal anesthesia</time_frame>
    <description>0 = calm, 1 = facial grimacing, 2 = moaning, 3 = screaming, and 4 = unable to proceed because of restlessness or agitation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of patient's position</measure>
    <time_frame>before spinal anesthesia</time_frame>
    <description>0 = poor hip flexion, 1 = satisfactory hip flexion, 2 = good hip flexion, and 3 = optimal hip flexion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Pain</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>facia iliaca block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Precedex and ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ultrasound guided facia iliaca block</intervention_name>
    <description>Patient will received ultrasound guided fascia iliaca block by 20 ml Bupivacaine 0,25% .</description>
    <arm_group_label>facia iliaca block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous drug</intervention_name>
    <description>Patient will received intravenous injection of precedex 0.25mic/Kg and ketamine 0,2 mg/kg .</description>
    <arm_group_label>Precedex and ketamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Aged 18-60 years.&#xD;
&#xD;
          2. Hip fractures&#xD;
&#xD;
          3. Both sexes.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient refusal&#xD;
&#xD;
          2. Allergy to local anesthetics&#xD;
&#xD;
          3. Bleeding diathesis or history of anticoagulant use.&#xD;
&#xD;
          4. impaired cognition or dementia&#xD;
&#xD;
          5. . Infection of the skin at the site of needle punctures area&#xD;
&#xD;
          6. multiple fractures&#xD;
&#xD;
          7. Any previous analgesic administration during the last 12 hours&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>hassan m. hetta, lecturer</last_name>
    <role>Principal Investigator</role>
    <affiliation>minia university/ faculty of medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>hassan m. hetta, lecturer</last_name>
    <phone>1010901114</phone>
    <phone_ext>0020</phone_ext>
    <email>hassan.hetta@mu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Minia University Hospital</name>
      <address>
        <city>Minya</city>
        <zip>61511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hassan m. hetta, lecturer</last_name>
      <phone>1010901114</phone>
      <phone_ext>0020</phone_ext>
      <email>hassan.hetta@mu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>January 20, 2023</study_first_submitted>
  <study_first_submitted_qc>January 20, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2023</study_first_posted>
  <last_update_submitted>March 13, 2023</last_update_submitted>
  <last_update_submitted_qc>March 13, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Hassan Mokhtar Elshorbagy Hetta</investigator_full_name>
    <investigator_title>lecturer of anesthesia and ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Femoral Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

